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Presynaptic axonal amyloid-β induces caspase-3 activation 
and neurodegeneration in the postsynaptic neuron
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                        It is assumed that the amyloid-beta peptide (AABSTRACT β) contributes to the neurodegen-
eration in Alzheimer’s disease (AD). Activation of an apoptotic pathway may play a key role 
in this process. The apoptotic signal may be driven by caspases. The presynaptic Aβ protein 
may be an activator of caspase-3 and could initiate a series of cascade events, which results in 
neurofi brillary degeneration in a postsynaptic cell. We report here that the axonic Aβ in the 
AD brain may be associated with caspase-3 activation. Our data suggest that caspase-3 in fact 
has a signifi cant role in the widespread neuronal cell death that occurs in AD brain. A subset 
of pyramidal cells in hippocampus area CA1 demonstrated widespread accumulation of tau-
protein. Individual postsynaptic neurons contained intracellular activated caspase-3 and were 
co-localized with neurofi brillary tangles. The results presented here support the suggestion 
that caspase-3 activation may lead to the neuronal cell death associated with AD. However, we 
are aware that, besides Aβ, other factors too may initiate a series of events which lead to the 
development of neurofi brillary tangles in the postsynaptic neurons.
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In Alzheimer’s disease (AD), the most common type of de-
mentia in advanced age, the loss of cortical and hippocampal 
neurons and synapses, is accompanied by the extracellular 
deposition of amyloid-beta peptide (Aβ) in senile plaques 
(SPs; Braak and Braak 1991). Paired helical fi laments con-
taining hyperphosphorylated tau-protein forms the neurofi -
brillary tangles (NFTs). The mechanism by which neurode-
generation occurs in AD is not yet understood (Bossy-Wetzel 
et al. 2004). Some investigators speculate that much of the 
cell loss may be due to apoptosis, a highly regulated form 
of programmed cell death (Cotman 1998). The caspases are 
therefore critical effectors of neuronal apoptosis and may be 
inappropriately activated in AD (Cowan et al. 2001; Cribbs et 
al. 2004; Johnson 1994). In particular, the analysis of caspase-
3-defi cient mice has revealed a decrease in apoptosis in the 
developing brain, suggesting that caspase-3 is necessary for 
the apoptosis of developing neurons. In AD brains, the protein 
level of caspase-3 is also increased (Rohm et al. 2001).
Some reports have indicated that Aβ (Estus et al. 1997) 
induces morphological and biochemical changes, with char-
acteristic apoptosis of the neurons. Aβ deposits have also been 
shown to be associated with both the presence of dystrophic 
neurites and the neuronal loss found in severely affected brain 
regions in AD (Selkoe 2002). 
These observations prompted us to investigate the possible 
involvement of caspase-3 in Aβ-induced apoptosis in autop-
sied human brain hippocampal samples. To study the relation-
ship between presynaptic Aβ deposition and the activation 
of caspase-3 in the postsynaptic neuron, we investigated the 
structural relationships of these proteins in autopsied human 
brain hippocampal samples. 
Materials and Methods
The primary antibodies used in this study were rabbit anti-
Aβ1-42 affi nity-purifi ed polyclonal antibody from Chemicon 
International Inc. (Temecula, CA, USA), caspase-3 active 
form (biotin-conjugated, polyclonal rabbit from BD Biosci-
ences Pharmingen, San Diego, CA, USA) and monoclonal 
anti-τ(tau) antibody produced in mouse (Sigma-Aldrich, St. 
Louis, MO, USA). Normal goat serum, normal sheep serum 
and 3,3’-diaminobenzidine tetrahydrochloride (DAB) were 
from Sigma-Aldrich (St. Louis, MO, USA). Biotin-SP-Af-
fi niPure-sheep anti-mouse IgG (H+L), peroxidase-streptavi-
din from Jackson (West Grove, PA, USA). Histoclear II and 
Histomount were from National Diagnostics (Atlanta, GA, 
USA). All chemicals used were of the highest grade available, 
from various suppliers.
Immunohistochemistry 
Autopsied brain tissues from the hippocampus of 5 neu-
ropathologically confi rmed AD cases and 6 non-demented 
cases displaying no evidence of NFTs were studied. The age 
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at death was not signifi cantly different for the AD (mean, 69 
± 7.2 years) and the controls (mean, 64 ± 6.8). The autopsied 
brain tissues used in this study were provided by the Depart-
ment of Pathology, Elisabeth Hospital, Hodmezovasarhely, 
Hungary.
Coronal sections 30-µm in thickness were cut with a 





, washed in phosphate-buffered saline (PBS; pH 7.4), 
treated with 0.1 M PBS containing 2.5% Triton X-100 for 
20 min and then incubated with the normal blocking serum 
for 60 min. The sections were thereafter incubated with 
the primary antibody at 4°C overnight. The dilutions of the 
individual antibodies were as follows: Aβ: 1:2000, activated 
caspase-3: 1:800 and tau: 1:2000. After three 10-min washes 
in PBS, the brain slices were incubated with the secondary 
antibody. When single staining was applied for demonstra-
tion of the localization either of Aβ or of activated caspase-3, 
the peroxidase complex was visualized by incubating the 
sections with 0.05 M Tris-HCl (pH 7.5) containing 0.05% 
DAB, 0.1% NiCl
2




, resulting in a bluish-
black colour. When double-stained sections were prepared 
(stained either for Aβ and tau or for activated caspase-3 and 
tau), the samples were developed fi rst in DAB dissolved in 
0.05 M Tris-HCl buffer. This staining resulted in a brownish 





 to eliminate the possibility persistent activity of 
the marker enzyme. After the staining for the second antibody, 
the peroxidase complex was visualized by incubating the 
sections in a DAB-NiCl
2
 mixture. In these double-stained 
sections, a brownish colour could be detected in some cell 
bodies, intermingled with a bluish-black colour (Kasa et al. 
2001). Controls were performed to rule out non-specifi c im-
munostaining by eliminating the primary or secondary anti-
body. The sections were next mounted, air-dried, dehydrated 
in an ethyl alcohol series, cleared in Histoclear, and fi nally 
coverslipped using Histomount. Photos were taken under 
normal light fi eld microscopy conditions (Nikon Microphot-
FXA microscope). 
Results
To investigate the morphological localization of Aβ in hip-
pocampus area CA1, an affi nity-purifi ed polyclonal antibody 
was used. The immunoreactivity was revealed not only in the 
SPs (Fig. 1A), but also in the axon varicosities (at the syn-
aptic sites; Fig. 1B) and within the neuronal cell body (Fig. 
1C). Some of the stained axon varicosities could be localized 
near the perikaryon and attached to the primary dendrite of a 
pyramidal cell (Fig. 1D).
When the samples were double-stained for Aβ and for tau, 
much to our surprise, a number of Aβ-stained axon varicosi-
ties were revealed on the surface of the tau-immunopositive 
neurons (Figs. 2A, B). It was interesting that the axon vari-
cosities were not uniformly distributed over the dendrite, but 
were rather located consecutively, separated by distance of 
a few microns.
In the control hippocampal samples, very few activated-
caspase-3-positive pyramidal cells were detected (Fig. 2C). 
Similarly, in the area dentate, stained neurons were rarely 
seen. The most interesting observation concerned the ap-
pearance of the staining. It appeared intermittently rather 
than evenly in the dendrites. In a Braak and Braak stage II 
AD sample, some tau were immunopositive for activated 
caspase-3 (Fig. 2E), while many more NFT-positive cells 
stained for caspase-3 (Fig. 2F) in a severe AD case (Braak 
and Braak stages V and VI).
To examine a possible relationship between caspase-3 
activation and tau-positive neurons, double-labelling experi-
ments were undertaken, using the caspase-3 active form and 
monoclonal anti-tau antibody as markers for NFT forma-
tion. As shown in Fig. 3A, only a subset of neurons was 
caspase-3-positive, and the number of cells was even lower 
for which tau could be clearly be seen in the same neuron. 
The co-localization of caspase-3 and tau was evident within 
individual neurons (Figs. 3A, B). Figure 3B illustrates a high-
magnifi cation image of typical caspase-3 and tau staining in 
the pyramidal neuron in hippocampus area CA1. Interestingly, 
the appearance of neurons labelled with caspase-3 was similar 
to that of those with tau. Other stained samples provided fur-
ther evidence that not all caspase-3-positive neurons contain 
tau pathology (Figs. 3C, D). Taken together, these results 
suggest that caspase-3 activation may occur in only a subset 
of the tau-bearing neurons. This suggestion is supported in 
Figs. 3E, F, where many more labelled neurons are present 
than in Fig. 3D.
Discussion 
In this report, we have demonstrated that Aβ is not only 
present in the SPs and neuronal perikarya, but may also be 
localized in the axons (Chen et al. 2004). There is experimen-
tal evidence suggests that Aβ accumulation in the cells may 
precede tau formation in the AD brain, and can potentiate 
the development of NFTs in transgenic mice. Furthermore, 
Aβ-induced neurodegeneration requires tau expression and 
the intracellular assembly of pathological tau filaments 
(Rissman et al. 2004). The appearance of intracellular Aβ is 
also observed in Down syndrome patients with AD, indicat-
ing that intraneuronal Aβ may be a common feature of AD 
subtypes. 
The activation of caspase-3 (Stadelmann et al. 1999; Su et 
al. 2001) in the postsynaptic dendrite by presynaptic Aβ again 
precedes the appearance of tau positivity in the pyramidal 
cells of hippocampus area CA1 in human brain samples. By 
using antibodies specifi c for the active form of caspase-3, tau 
and Aβ, we could underline such a sequence of events. It is 
suggested that the various caspases (among them caspase-3) 
are activated only during apoptosis (Rohn et al. 2001; Sal-
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Figure 1. Immunohistochemical localization of Aβ in hippocampal area CA1. Specifi c Aβ staining appears in the SPs (A, arrow), in the axon 
varicosities (B, arrow) and in the SPs (B, double arrows). In C, specifi c Aβ immunoreactivity is present in the perikarya of a neuron (arrow). Some 
other neurons are covered with Aβ-positive axon varicosities (arrow), while diffuse staining (double-arrow) is to be seen among the neuropil. 
Scale bar: 50 µm
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Figure 2. Double-labelling immunohistochemical analysis for Aβ and tau. In A and B, the brownish staining within the neurons indicates the pres-
ence of tau, while the black dots (A and B, arrows) on the surface of the pyramidal cells illustrate the Aβ-positive axon varicosities. Figure 2C,D 
reveal the activated caspase-3 in the dendrites and the cell body in a control sample. The staining pattern appears intermittently in the dendrites 
(arrows). In contrast, in Braak and Braak stages II (E, arrows) and VI (F, arrows), the caspase-3 appears in the cell bodies. Scale bar = 50 μm 
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Figure 3. Activated caspase-3 labelling of tau-bearing hippocampal neurons in control samples. A: Double-labelling immunohistochemical analysis 
for caspase-3 (arrows) and tau (double-arrows) illustrates that only a subset of neurons are caspase-3-positive (bluish-black) and can be clearly 
differentiated from tau-containing neurons (brownish, double-arrows). B: Co-localization of caspase-3 (arrow) and tau (double-arrow) within 
a neuron. C and D: Double-immunostaining of a hippocampal tissue section from an early stage of AD (C) and a severe AD case, showing the 
distribution of caspase-3-positive and tau-stained neurons. In C, the caspase-3-positive neurons (arrows) seem to precede the appearance of 
tau-positive (arrowheads) cells. The number of tau-positive neurons (arrowheads) increases with disease severity (D), where only a few (arrow) 
caspase-3-positive neurons can be revealed. A similar distribution of tau-positive neurons can be demonstrated with the specifi c antibody for 
tau. In A, the number of stained neurons is lower than in the severe case of AD (F). Scale bar: 25 μm 
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znick et al. 1999; Slee et al. 1999); we therefore believe that 
in our samples some of the neurons die by apoptosis. Accord-
ingly, our results suggest that caspase-3 activation may begin 
at the synapse and, after a trans-synaptic signal it propagates 
in the dendrite in a retrograde fashion to the neuronal cell bod-
ies. The Aβ signal therefore induces a sequence of processes 
which, among others, ultimately result in caspase-3 activation, 
tau hyperphosphorylation, apoptosis, neurofi brillary degen-
eration and fi nally cell death. We are aware, however, that, 
even though we have demonstrated that activated caspase-3 
and tau formation are present within the same neurons, this 
does not imply that they must be causally interrelated events. 
Indeed, we were able to detect only one subset of neurons in 
which caspase-3 and tau were co-localized. In another subset 
of nerve cells, either only caspase-3 or only tau was detected. 
Nevertheless this does not rule out the possibility of a causal 
relationship between the two processes. 
It is interesting to note that, in the control brain, only 
scattered cells exhibited caspase-3 positivity, while in the 
earlier stages of AD stage I and II (Braak and Braak 1991) 
more activated caspase-3 neurons are present than tau-positive 
nerve cells. In contrast, in the advanced stages of AD stage V 
and VI (Braak and Braak 1991), more tau-positive structures 
appear than activated caspase-3 nerve cells. 
In conclusion, our data support the suggestion that the 
presynaptic axonal Aβ may be an initiator of the death of the 
postsynaptic neuron. This suggestion is supported by the ap-
pearance of caspase-3 positivity in those neurons that are in 
close contact with Aβ-positive axon varicosities. The precise 
mechanisms underlying the Aβ-induced neuronal degenera-
tion await further elucidation. 
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